Badens Catherine, Guizouarn Hélène
APHM Department of Medical Genetics, Hôpital de la Timone, Aix Marseille Univ, INSERM, GMGF, Marseille, France.
Univ. Nice Sophia Antipolis, CNRS, Inserm, iBV, 06100 Nice, France.
Br J Haematol. 2016 Sep;174(5):674-85. doi: 10.1111/bjh.14197. Epub 2016 Jun 29.
Genetic defects of erythrocyte transport proteins cause disorders of red blood cell volume that are characterized by abnormal permeability to the cations Na(+) and K(+) and, consequently, by changes in red cell hydration. Clinically, these disorders are associated with chronic haemolytic anaemia of variable severity and significant co-morbidities, such as iron overload. This review provides an overview of recent insights into the molecular basis of this group of rare anaemias involving cation channels and transporters dysfunction. To date, a total of 5 different membrane proteins have been reported to be responsible for volume homeostasis alteration when mutated, 3 of them leading to overhydrated cells (AE1 [also termed SLC4A1], RHAG and GLUT1 [also termed SCL2A1) and 2 others to dehydrated cells (PIEZO1 and the Gardos Channel). These findings are not only of basic scientific interest, but also of direct clinical significance for improving diagnostic procedures and identify potential approaches for novel therapeutic strategies.
红细胞转运蛋白的遗传缺陷会导致红细胞体积紊乱,其特征是对阳离子Na(+)和K(+)的通透性异常,进而导致红细胞水合作用的改变。临床上,这些紊乱与严重程度各异的慢性溶血性贫血以及显著的合并症有关,如铁过载。本综述概述了对这组涉及阳离子通道和转运蛋白功能障碍的罕见贫血症分子基础的最新见解。迄今为止,共有5种不同的膜蛋白被报道在发生突变时会导致体积稳态改变,其中3种会导致细胞过度水化(AE1 [也称为SLC4A1]、RHAG和GLUT1 [也称为SCL2A1]),另外2种会导致细胞脱水(PIEZO1和加尔多斯通道)。这些发现不仅具有基础科学意义,对于改进诊断程序和确定新治疗策略的潜在方法也具有直接的临床意义。